Startseite
Märkte
Charts & Ideen
Algo
Nachrichten
Store
Broker
Herunterladen
Wirtschaftskalender
Handelssignale
WebTerminal
Geben Sie
/
ein, um zu suchen: @user, $symbol
Suche
Einloggen
Eröffnen Sie ein Konto
Deutsch
English
Русский
中文
Español
Português
日本語
한국어
Français
Italiano
Türkçe
CUE
#3645
Cue Biopharma, Inc.
0.2
8
0.00%
Sektor:
Basis:
Gewinnwährung:
Tagesspanne
Jahresspanne
Tagesänderung
0.00%
Monatliche Änderung
-26.32%
6 month change
-65.85%
Jahresänderung
-76.47%
Vorheriger Schlusskurs
0.2
8
Open
0.2
8
Bid
Ask
Low
0.2
8
High
0.2
8
Volumen
6
Märkte
Aktien
Gesundheitswesen
CUE
Open full chart
Financials
Overview
Finanzbericht
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
30.46 M
33.01 M
43.17 M
48.64 M
61.82 M
—
Valuation ratios
Enterprise value
306.15 M
308.98 M
71.32 M
90.95 M
44.96 M
170.83 M
Price to earnings ratio
—
—
-1.79
-2.5
-1.51
-5.9
Price to sales ratio
—
—
178.44
18.89
6.09
24.43
Price to cash flow ratio
—
—
-2.27
-3.18
-1.69
-6.49
Price to book ratio
—
—
1.44
3.43
3.51
5.82
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
-0.45
-0.53
-0.58
0.82
1.26
1.29
Return on equity %
-0.57
-0.67
-0.81
1.37
2.32
3.43
Return on invested capital %
-849.98
-804.24
-1 067.99
—
952.32
—
Gross margin %
100
100
100
100
100
400
Operating margin %
-1 427.96
-292.56
-10.02 K
774.3
411.58
3 427.21
EBITDA margin %
—
—
—
—
—
—
Net margin %
-1 419.79
-295.56
-9 975.38
753.27
403.39
3 399.86
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
5.36
5.35
6.68
3.01
1.84
6.13
Inventory turnover
—
—
—
—
—
—
Asset turnover
0.04
0.16
0.01
0.09
0.22
0.22
Solvency ratios
Debt to assets ratio
—
—
0.09
0.07
0
0.02
Debt to equity ratio
—
—
0.12
0.11
0
0.03
Long term debt to total assets ratio
—
—
0.09
0.07
0
0
Long term debt to total equity ratio
—
—
0.12
0.11
0
0
Per share metrics
Operating cash flow per share
—
—
-1.17
0.87
0.64
0.4
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
0.23
0.09
0
0.01
Cash per share
—
—
2.14
1.06
0.4
1.05
Net current asset value per share
—
—
2.17
1.12
0.45
1.24
Tangible book value per share
—
—
1.84
0.81
0.31
0.72
Working capital per share
—
—
1.84
0.75
0.2
0.43
Book value per share
—
—
1.84
0.81
0.31
0.72
Nachrichten
Cue Biopharma sichert sich 10 Millionen US-Dollar durch Kapitalerhöhung zu 0,28 US-Dollar je Aktie
Cue Biopharma prices $10 million public offering at $0.28 per share
Kapitalerhöhung angekündigt: Aktie von Cue Biopharma bricht ein
Cue Biopharma stock tumbles on public offering announcement
Cue Biopharma plant Kapitalerhöhung durch Ausgabe neuer Aktien und Warrants
Cue Biopharma launches public offering of common stock and warrants
Citizens bestätigt "Market Outperform" für Cue Biopharma mit Kursziel von 2,00 $
Cue Biopharma stock rating reiterated at Market Outperform by Citizens
ImmunoScape lizenziert Technologie von Cue Biopharma für neuartige Krebstherapie
ImmunoScape licenses Cue Biopharma technology for novel cancer therapy
Cue Biopharma: EPS übertrifft Schätzungen um 0,02 $ - Umsatz schlechter als erwartet
Cue Biopharma earnings beat by $0.02, revenue fell short of estimates